Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8051
LCNB Corp
LCNB
$288M
| $616K | ﹤0.01% |
40,722
+4,122
| +11% | +$66K |
|
8052
Innovator Nasdaq-100 Managed Floor ETF
QFLR
$523M
| $616K | ﹤0.01% |
+21,064
| New | +$602K |
|
8053
CALL
Ezcorp Inc
EZPW
$1.79B
| $616K | ﹤0.01% |
50,400
+9,700
| +24% | +$115K |
|
8054
PUT
Direxion Daily MSFT Bull 2X ETF
MSFU
$657M
| $616K | ﹤0.01% |
15,600
-11,300
| -42% | -$478K |
|
8055
Utah Medical Products
UTMD
$229M
| $615K | ﹤0.01% |
10,003
-6,918
| -41% | -$447K |
|
8056
PUT
QuidelOrtho
QDEL
$921M
| $615K | ﹤0.01% |
13,800
-5,900
| -30% | -$241K |
|
|
ACLO
8057
TCW AAA CLO ETF
ACLO
$537M
| $615K | ﹤0.01% |
+12,264
| New | +$615K |
|
8058
CALL
UroGen Pharma
URGN
$2.39B
| $615K | ﹤0.01% |
57,700
+47,900
| +489% | +$573K |
|
8059
Fidelity Hedged Equity ETF
FHEQ
$964M
| $614K | ﹤0.01% |
+22,371
| New | +$619K |
|
8060
JPMorgan BetaBuilders Emerging Markets Equity ETF
BBEM
$843M
| $614K | ﹤0.01% |
12,041
+768
| +7% | +$41.3K |
|
8061
Global X Internet of Things ETF
SNSR
$215M
| $614K | ﹤0.01% |
+17,596
| New | +$621K |
|
8062
PUT
Installed Building Products
IBP
$6.34B
| $613K | ﹤0.01% |
3,500
-1,900
| -35% | -$413K |
|
8063
CALL
Smith & Wesson
SWBI
$635M
| $613K | ﹤0.01% |
60,700
-5,000
| -8% | -$62.6K |
|
8064
FlexShares Quality Dividend Defensive Index Fund
QDEF
$559M
| $613K | ﹤0.01% |
8,733
-11,442
| -57% | -$824K |
|
8065
PUT
Weibo
WB
$1.86B
| $613K | ﹤0.01% |
64,200
-25,400
| -28% | -$243K |
|
8066
CNO Financial Group
CNO
$5.04B
| $613K | ﹤0.01% |
16,472
-52,916
| -76% | -$1.97M |
|
|
PFC
8067
DELISTED
Premier Financial Corp. Common Stock
PFC
| $613K | ﹤0.01% |
+23,969
| New | +$625K |
|
8068
PUT
Bank of Hawaii
BOH
$3.12B
| $613K | ﹤0.01% |
8,600
-700
| -8% | -$50.5K |
|
8069
PUT
Cellebrite
CLBT
$2.76B
| $612K | ﹤0.01% |
27,800
+23,700
| +578% | +$456K |
|
8070
CALL
LivePerson
LPSN
$35M
| $612K | ﹤0.01% |
26,847
+5,774
| +27% | +$88.3K |
|
8071
CALL
LifeVantage
LFVN
$80.4M
| $612K | ﹤0.01% |
34,900
+8,700
| +33% | +$122K |
|
8072
PUT
NGL Energy Partners
NGL
$2.17B
| $612K | ﹤0.01% |
122,600
+37,300
| +44% | +$167K |
|
8073
iShares iBonds Dec 2033 Term Treasury ETF
IBTO
$464M
| $612K | ﹤0.01% |
25,888
+9,783
| +61% | +$236K |
|
8074
Global X Defense Tech ETF
SHLD
$7.73B
| $611K | ﹤0.01% |
+16,343
| New | +$631K |
|
|
GOOS
8075
PUT
Canada Goose Holdings
GOOS
$831M
| $611K | ﹤0.01% |
60,900
+21,800
| +56% | +$223K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.